Research

Research

Assessing Clinical and Economic Value

PMC studies the clinical and economic value of personalized health care approaches across a broad range of disease states. Ongoing research is examining the benefits of personalized medicine for patients with suspected rare diseases. Other studies are relating overall improvements in clinical care to the implementation of personalized medicine. This work will advance peer-reviewed evidence necessary to help payers and providers make decisions about the circumstances in which they should adopt policies and programs that provide access to the tests and treatments underpinning personalized medicine.

2021

Evaluating the Clinical and Economic Value of Sequencing-Based Diagnostic Tests for Patients With Rare and Undiagnosed Diseases

Improvements in Clinical Care Associated With Personalized Medicine

2020

"Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer," Clinical Lung Cancer

2019

"Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer," JCO Clinical Cancer Informatics

"One Size Does Not Always Fit All in Value Assessment," American Journal of Managed Care

2017

Personalized Medicine and Value Assessment Frameworks: Context, Considerations, and Next Steps